Transition Metal Dichalcogenides (TMDC)-Based Nanozymes for Biosensing and Therapeutic Applications

Full item record

dc.contributor.authorPresutti, Dario
dc.contributor.authorAgarwal, Tarun
dc.contributor.authorZarepour, Atefeh
dc.contributor.authorCelikkin, Nehar
dc.contributor.authorHooshmand, Sara
dc.contributor.authorNayak, Chinmay
dc.contributor.authorGhomi, Matineh
dc.contributor.authorZarrabi, Ali
dc.contributor.authorCostantini, Marco
dc.contributor.authorBehera, Birendra
dc.contributor.authorMaiti, Tapas Kumar
dc.contributor.organizationInstitute of Physical Chemistry, Polish Academy of Sciences,en
dc.contributor.organizationDepartment of Biotechnology, Indian Institute of Technology, Kharagpur, West Bengal, Indiaen
dc.contributor.organizationDepartment of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul, Turkeyen
dc.contributor.organizationNanotechnology Research and Application Center (SUNUM), Sabanci University, Tuzla, Istanbul, Turkeyen
dc.contributor.organizationDepartment of Biotechnology and Bioinformatics, Sambalpur University, Sambalpur, Odisha, Indiaen
dc.contributor.organizationChemistry Department, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iranen
dc.description.abstractNanozymes, a type of nanomaterial with enzyme-like properties, are a promising alternative to natural enzymes. In particular, transition metal dichalcogenides (TMDCs, with the general formula MX2, where M represents a transition metal and X is a chalcogen element)-based nanozymes have demonstrated exceptional potential in the healthcare and diagnostic sectors. TMDCs have different enzymatic properties due to their unique nano-architecture, high surface area, and semiconducting properties with tunable band gaps. Furthermore, the compatibility of TMDCs with various chemical or physical modification strategies provide a simple and scalable way to engineer and control their enzymatic activity. Here, we discuss recent advances made with TMDC-based nanozymes for biosensing and therapeutic applications. We also discuss their synthesis strategies, various enzymatic properties, current challenges, and the outlook for future developments in this field.en
dc.description.sponsorshipThis work is supported by the National Science Centre Poland (NCN) within PRELUDIUM19 Project No. 2020/37/N/ST5/03272 to NC. The authors are grateful for the support to this work also provided by the National Science Centre Poland (NCN) within OPUS 19 Project No. 2020/37/B/ST8/02167 to MC.en
dc.identifier.citationPresutti, D.; Agarwal, T.; Zarepour, A.; Celikkin, N.; Hooshmand, S.; Nayak, C.; Ghomi, M.; Zarrabi, A.; Costantini, M.; Behera, B.; et al. Transition Metal Dichalcogenides (TMDC)-Based Nanozymes for Biosensing and Therapeutic Applications. Materials 2022, 15, 337.
dc.rightsUznanie autorstwa 4.0 Międzynarodowe*
dc.subjecttransition metal dichalcogenidesen
dc.titleTransition Metal Dichalcogenides (TMDC)-Based Nanozymes for Biosensing and Therapeutic Applicationsen
Files for this record
Original bundle
Now showing 1 - 1 of 1
Name: materials-15-00337.pdf
Size: 2.29 MB
Format: Adobe Portable Document Format
License files
Name: license.txt
Size: 233 B
Format: Plain Text